Cleanspace Holdings Limited

CSX

CleanSpace Holdings Ltd. designs, manufactures and sells workplace respiratory protection equipment for healthcare and industrial end markets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2020-10-23. The firm provides respiratory protection equipment for healthcare and industrial applications. The Company’s product offerings include CleanSpace HALO, CleanSpace2, CleanSpace ULTRA and CleanSpace EX. The firm provides a clinically designed powered air purifying respirator (PAPR) system, CleanSpace Halo, which is compatible with other personal protective equipment (PPE) and clinical head gear. CleanSpace2 is suitable for industries such as metal fabrication and welding; chemical or biological material handling; maintenance and cleaning; grain and food handling; high dust environments; mining and quarry; and stone, cement and concrete handling. Its subsidiaries include CleanSpace IP Pty Ltd, CleanSpace Technology Pty Limited, CleanSpace Americas, Inc, CleanSpace Technology Singapore Pte Ltd and CleanSpace NZ Ltd.

Constellation Technologies Limited

CT1

Constellation Technologies Ltd. specializes in Internet of Things (IoT) product development and product management. The company is headquartered in Melbourne, Victoria. The firm is focused on offering solutions to market, which leverage cloud, IoT, edge-computing sensors, big data, analytics, machine learning (ML), artificial intelligence (AI) and other advanced technologies. The firm through Callisto offers a range of solutions designed to address various industry needs. These solutions include Food Safety & Compliance, Drugs & Medicine Monitoring, Cold Chain Logistics, and Asset Management. Its Gen3 IoT product line offers IoT devices that can capture critical data points across a range of applications, providing its customers with reliable and flexible solutions that support multiple communication networks and sensor customization. Its MeridianCT is a cloud-based software platform and mobile application, which enables users to have an end-to-end IoT data solution to connect, monitor and visualize their data.

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Clean Seas Seafood Limited

CSS

Clean Seas Seafood Ltd. engages in the propagation of kingfish and produces fingerlings for sale. The principal activities of the Company are propagation of Spencer Gulf Yellowtail Kingfish, producing fingerlings for sale and grow out and grow out of Spencer Gulf Yellowtail Kingfish for harvest and sale. Its hatchery and farms are located on South Australia’s Spencer Gulf. Its brands include Spencer Gulf Kingfish and South Australian Yellowtail. The company is also a producer of aquaculture Yellowtail Kingfish outside of Japan. Its subsidiaries include Clean Seas Aquaculture Growout Pty Ltd and Clean Seas Seafood International Pty Ltd.